Parkwood LLC Has $17.06 Million Stake in CVS Health Corporation $CVS

Parkwood LLC reduced its stake in shares of CVS Health Corporation (NYSE:CVS) by 9.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 164,882 shares of the pharmacy operator’s stock after selling 17,127 shares during the quarter. Parkwood LLC’s holdings in CVS Health were worth $17,057,000 as of its most recent filing with the SEC.

Several other large investors have also recently added to or reduced their stakes in CVS. Caitong International Asset Management Co. Ltd raised its holdings in shares of CVS Health by 407.2% during the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 281 shares in the last quarter. Swiss RE Ltd. bought a new position in CVS Health during the fourth quarter valued at about $26,000. Kilter Group LLC bought a new stake in shares of CVS Health during the 2nd quarter worth about $27,000. Sankala Group LLC acquired a new position in shares of CVS Health during the 4th quarter valued at about $28,000. Finally, Global Trust Asset Management LLC raised its stake in shares of CVS Health by 344.8% in the 1st quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock valued at $28,000 after acquiring an additional 300 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have commented on CVS. Truist Financial lifted their price target on shares of CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. TD Cowen lifted their price objective on CVS Health from $105.00 to $110.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. HSBC reaffirmed a “hold” rating and issued a $103.00 target price on shares of CVS Health in a report on Monday, July 6th. Royal Bank Of Canada raised their price objective on shares of CVS Health from $107.00 to $113.00 and gave the stock an “outperform” rating in a research note on Thursday, July 9th. Finally, Piper Sandler reissued an “overweight” rating on shares of CVS Health in a report on Wednesday. Twenty-two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $107.17.

CVS Health Price Performance

NYSE:CVS opened at $94.22 on Thursday. The company has a market capitalization of $120.50 billion, a price-to-earnings ratio of 24.93, a PEG ratio of 0.84 and a beta of 0.61. The company has a 50-day moving average of $101.63 and a 200-day moving average of $89.33. CVS Health Corporation has a 52 week low of $69.51 and a 52 week high of $110.68. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. The firm had revenue of $106.10 billion during the quarter, compared to analysts’ expectations of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company’s revenue for the quarter was up 7.3% compared to the same quarter last year. During the same quarter last year, the company earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, equities research analysts anticipate that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date was Thursday, July 23rd. CVS Health’s dividend payout ratio is 70.37%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.